Arcutis Biotherapeutics Inc. ARQT
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Arcutis Biotherapeutics Inc. is a commercial-stage biopharmaceutical company specializing in medical dermatology treatments for immune-mediated skin diseases. It develops and commercializes innovative topical therapies, with its flagship product ZORYVE (roflumilast) available as a steroid-free cream and foam formulatio…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees354
TickerARQT
Statistics
Market Cap$3.31B
Revenue (TTM)$376.1M
Net Income-$16.1M
Net Margin-4.3%
EPS$-0.13
P/E-189.15
P/S7.05
P/B15.45
EV/EBITDA501.80
ROE-1.4%
Dividend Yield—
Price$26.44
Data: Twelve Data · Revenue = mcap / P/S